MySmarTrend
← Insider Monitor
Maze Therapeutics, Inc. logo
MAZE

Maze Therapeutics, Inc.

Nasdaq · Biological Products, (No Diagnostic Substances)

1
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Maze Therapeutics is a biopharmaceutical company that uses human genetics to identify disease-modifying drug targets, developing small-molecule therapies for conditions including kidney disease, cardiometabolic disorders, and other genetically defined indications.

Industry
Biological Products, (No Diagnostic Substances)
Headquarters
South San Francisco, CA
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Dandekar AtulCSBOSell$207KAug 28, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for MAZE.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable MAZE activity by email

Free alerts for the insider and congressional trades worth watching.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.